Switching to a once-daily bictegravir/lenacapavir (BIC/LEN) single-tablet regimen is generally well tolerated through 48 ...

Share on Pinterest A drug used to treat HIV infections can also effectively prevent them, a new clinical trial demonstrates. Image credit: luza studios/Getty Images. Human immunodeficiency virus (HIV) ...

Only one person has developed a new HIV infection during a year-long extension of the landmark PURPOSE 1 and PURPOSE 2 trials testing twice-yearly injectable lenacapavir (Yeztugo) for pre-exposure ...

South Africa has 8 million people living with HIV, and the government has introduced lenacapavir, a new HIV prevention drug.

All 46 people with HIV who started long-acting lenacapavir and cabotegravir at a University of California, San Francisco, ...

Lenacapavir, a twice-yearly injectable, offers a new HIV prevention method, improving adherence compared to more frequent regimens. Phase 3 trials showed lenacapavir's high efficacy in preventing HIV, ...

Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers breaking ...

Use of lenacapavir in people with HIV who are heavily treatment-experienced resulted in high levels of virologic suppression, according to two small studies presented at the Infectious Disease Week ...

Makoni is a Zimbabwean-born medical student at the Medical College of Wisconsin. When I was 5, I traced the fabric of my mother’s gumbezi as sunlight fell across the floor of my grandparents’ home in ...

Share on Pinterest The WHO has recommended the use of lenacapavir to help prevent HIV. Jakub Porzycki/NurPhoto via Getty Images The human immunodeficiency virus (HIV), which can lead to acquired ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...